Neurosterix raises $105M in Series B to advance schizophrenia drug candidate with Codefy veterans leading.
Amount Raised
$105 Million
Round Type
Series B
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Neurosterix has secured $105 million in Series B funding to advance its lead schizophrenia candidate. The round reunites key figures previously behind Codefy who are now driving the company's clinical development. The funding will support the continued progress of Neurosterix's psychiatric medicine pipeline. The company is focused on developing novel treatments for schizophrenia.
Quick answer
Neurosterix raised $105 Million in a Series B round, dated November 11, 2026. Neurosterix is based in New York, New York, United States.
- How much did Neurosterix raise?
- Neurosterix raised $105 Million in a Series B round on November 11, 2026.
- What does Neurosterix do?
- Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of patients suffering from neurological disorders.
- Where is Neurosterix based and how big is it?
- Neurosterix is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Neurosterix that raised within 45 days of this round, from Fundz verified event records.
- Biograil raised $22M on November 4, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
Who to call at Neurosterix, and when
A new round usually means Neurosterix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neurosterix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurosterix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurosterix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurosterix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansNeurosterix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.